Try digitalPLUS for 10 days for only $0.99

Topics

Christopher L. Smith
Mikulski bill would speed approval of new drugs by FDA
Mikulski bill would speed approval of new drugs by FDA

Drugs for chronic conditions such as Alzheimer's disease and diabetes would move through the Food and Drug Administration approval process more rapidly under a bipartisan bill Sen. Barbara A. Mikulski will unveil Thursday. The legislation, which will have Republican co-sponsors in the House and Senate, would direct $50 million to increase the number of experimental drugs that enter the FDA approval pipeline. To receive a grant under the program, private companies would have to put up $2 for every $1 spent by taxpayers. "By acting now, we can save billions in future health care spending and long-term care costs," the Maryland Democrat said in a statement. "This bill...

Loading

81°